Cybrdi (CYDI) Inventory Turnover Ratio, from third quarter 2014 to third quarter 2013, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Cybrdi, Inc.  (CYDI)
 

Cybrdi Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Cybrdi's Inventory turnover ratio has remained unchanged compare to previous quarter at 0.49 in the third quarter 2014Average processing period, for Cybrdi's inventories remained unchanged at 745 days, in the Sep 30 2014 quarter.

Within Healthcare sector 302 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1740 in the second quarter 2014, to 1756.

CYDI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Cybrdi, Inc. Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CYDI Inventory Turnover Ratio (Sep 30 2014)
III. Quarter		 (Jun 30 2014)
II. Quarter		 (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter
Y / Y Inventory Growth -5.09 % -2.74 % -3.31 % 3.92 % -11.2 %
Y / Y Cost of Sales Growth -5.46 % -11.03 % 22.82 % -59.79 % 3.08 %
Inventory Turnover Ratio (TTM) 0.49 0.49 0.5 0.47 0.63
CYDI's Total Ranking # 1756 # 1740 # 1746 # 0 # 2021
Average inventory processing period 740 740 728 783 580
Seq. Inventory Growth -0.82 % 1.44 % -5.98 % 0.34 % 1.64 %
Seq. Cost of Sales Growth 15.24 % -43.81 % 59.18 % -8.28 % 8.44 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 21
Healthcare Sector # 303
Overall Market # 1756

Inventory Turnover Ratio Statistics
High Average Low
0.68 0.53 0.41
(Dec 31 2012)   (Sep 30 2012)



CYDI Company Profile >> Back to CYDI Efficiency Comparisons >> Compare CYDI Inventory Turnover Ratio to its Competitors

Financial Statements
Cybrdi's Inventories $ 1 Millions Visit CYDI's Balance sheet
Cybrdi's Cost of Revenues TTM $ 0 Millions Visit CYDI's Income Statement
What are CYDI's Sales? Visit CYDI's Sales by Segment

Other Inventory Turnover Ratios
Cybrdi's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CYDI's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CYDI's Competitors
Inventory Turnover Ratio for CYDI's Suppliers
Inventory Turnover Ratio for CYDI's Customers

You may also want to know
CYDI's Sales Growth Rates CYDI's Pe Price to earnings ratio CYDI's Receivables Turnover Ratio CYDI's Stock Quote
CYDI's Net Income Growth Rates CYDI's Ps Price to Sales ratio CYDI's Sales per Employee CYDI's Asset Turnover Ratio
CYDI's Net Margin CYDI's Pb Price to Book ratio CYDI's Financial Strength Ratios CYDI's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2014, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2014 Inventories at quarter ending Sep 30 2014
Alexion Pharmaceuticals Inc   1.37 $ 175.975  Millions$ 128  Millions
Dyax Corp  1.37 $ 4.407  Millions$ 3  Millions
Oragenics Inc   1.36 $ 0.358  Millions$ 0  Millions
Trivascular Technologies, Inc.  1.35 $ 10.500  Millions$ 8  Millions
Nephros Inc   1.35 $ 0.211  Millions$ 0  Millions
Cellular Biomedicine Group Inc   1.33 $ 0.251  Millions$ 0  Millions
Zogenix Inc   1.31 $ 19.483  Millions$ 15  Millions
Xtant Medical Holdings Inc   1.30 $ 13.893  Millions$ 11  Millions
Gt Biopharma Inc   1.29 $ 0.044  Millions$ 0  Millions
Asensus Surgical Inc   1.28 $ 0.660  Millions$ 1  Millions
Protalix Biotherapeutics inc   1.27 $ 9.028  Millions$ 7  Millions
Zoetis Inc   1.27 $ 1,692.000  Millions$ 1,333  Millions
Rti Surgical Holdings Inc   1.24 $ 133.496  Millions$ 107  Millions
Nuvasive Inc  1.24 $ 186.552  Millions$ 150  Millions
Quantrx Biomedical Corporation  1.24 $ 0.002  Millions$ 0  Millions
Inergetics Inc  1.19 $ 1.033  Millions$ 1  Millions
Camp4 Therapeutics Corporation  1.15 $ 18.032  Millions$ 16  Millions
Nanomix Corp  1.14 $ 0.159  Millions$ 0  Millions
Pfizer Inc  1.11 $ 6,875.000  Millions$ 6,209  Millions
Amgen Inc   1.10 $ 3,239.000  Millions$ 2,956  Millions
Axogen inc   1.07 $ 3.642  Millions$ 3  Millions
Celgene Corp  1.06 $ 375.500  Millions$ 355  Millions
Delcath Systems Inc   1.01 $ 0.619  Millions$ 1  Millions
Cv Sciences Inc   1.00 $ 3.579  Millions$ 4  Millions
International Stem Cell Corporation  0.95 $ 1.366  Millions$ 1  Millions
Cumberland Pharmaceuticals Inc   0.92 $ 6.024  Millions$ 7  Millions
Wright Medical Group N v   0.90 $ 71.549  Millions$ 79  Millions
Antares Pharma Inc   0.86 $ 6.399  Millions$ 7  Millions
Zimmer Biomet Holdings Inc   0.82 $ 932.800  Millions$ 1,131  Millions
China Pharma Holdings Inc  0.81 $ 17.784  Millions$ 22  Millions

Date modified: 2026-09-08T15:07:44+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.